Last reviewed · How we verify

Hydrocortisone And Acetic Acid (ACETIC ACID)

Hikma · FDA-approved approved Small molecule Quality 36/100

Hydrocortisone and Acetic Acid, originally developed by HI TECH PHARMA and currently owned by Hikma, is a small molecule acetic acid drug class targeting Tyrosine-protein kinase Lck. It was FDA approved in 1960 for the treatment of otitis externa. The drug is off-patent with 7 generic manufacturers, indicating it is commercially available as a generic product. Key safety considerations include the potential for local skin irritation and allergic reactions. This medication works by reducing inflammation and infection in the affected ear.

At a glance

Generic nameACETIC ACID
SponsorHikma
Drug classacetic acid
TargetTyrosine-protein kinase Lck
ModalitySmall molecule
Therapeutic areaImmunology
PhaseFDA-approved
First approval1960

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: